Early results from an experimental vaccine for glioblastoma, a type of brain cancer, show the potential to delay recurrence and double life expectancy in patients. NBC News’ Anne Thompson speaks with a neurosurgeon, scientist and patient about the findings’ potential impact.
CanceRx - CanceRx deploys a new application of finance to fund cancer research.
